@CONFERENCE{MTMT:34574471, title = {Primer tüdődaganatok sztereotaxiás ablatív radioterápiája: Kaposvári eredmények}, url = {https://m2.mtmt.hu/api/publication/34574471}, author = {Kalincsák, Judit and Toller, Gábor and Walter, Norbert and Somogyiné Ezer, Éva and Glavák, Csaba and Kovács, Péter and Petőné Csima, Melinda and Lakosi, Ferenc}, booktitle = {MST XVI. KONGRESSZUSA}, unique-id = {34574471}, year = {2023}, pages = {online}, orcid-numbers = {Walter, Norbert/0000-0002-8635-4656; Glavák, Csaba/0000-0003-1448-810X} } @article{MTMT:32838867, title = {Céltérfogat lefedettség valószínűségen („Coverage probability based”) alapuló szimultán integrált nyirokcsomó boost technika lokálisan előrehaladott méhnyakrák esetén: 2 éves eredmények}, url = {https://m2.mtmt.hu/api/publication/32838867}, author = {Lakosi, Ferenc and Kedves, András and Gulybán, Ákos and Toller, Gábor and Völgyi, Zoltán József and Faour, Amer and Bálint, András and Petrási, Bernadett and Glavák, Csaba}, journal-iso = {MAGYAR ONKOLÓGIA}, journal = {MAGYAR ONKOLÓGIA}, volume = {66}, unique-id = {32838867}, issn = {0025-0244}, year = {2022}, eissn = {2060-0399}, pages = {81-82}, orcid-numbers = {Glavák, Csaba/0000-0003-1448-810X} } @article{MTMT:32838847, title = {Brachyterápiás Acuros BV és TG-43 formalizmus összehasonlítása HDR cervixkezeléseknél}, url = {https://m2.mtmt.hu/api/publication/32838847}, author = {Nagy, Zoltán and Laboda, Brigitta and Antal, Gergely and Toller, Gábor and Kahán, Zsuzsanna and Cselik, Zsolt}, journal-iso = {MAGYAR ONKOLÓGIA}, journal = {MAGYAR ONKOLÓGIA}, volume = {66}, unique-id = {32838847}, issn = {0025-0244}, year = {2022}, eissn = {2060-0399}, pages = {74-74}, orcid-numbers = {Antal, Gergely/0000-0002-9259-6643; Kahán, Zsuzsanna/0000-0002-5021-8775} } @article{MTMT:32838837, title = {A közepes és magas rizikócsoportú prosztatadaganatok ellátása MRI-vezérelt HDR-AL közelterápiás boosttal: nyolcéves követés eredményei}, url = {https://m2.mtmt.hu/api/publication/32838837}, author = {Toller, Gábor and Antal, Gergely and Páll, János and Miovecz, Ádám and Farkas, Andrea and Petőné Csima, Melinda and Gulybán, Ákos and Lakosi, Ferenc}, journal-iso = {MAGYAR ONKOLÓGIA}, journal = {MAGYAR ONKOLÓGIA}, volume = {66}, unique-id = {32838837}, issn = {0025-0244}, year = {2022}, eissn = {2060-0399}, pages = {68-68}, orcid-numbers = {Antal, Gergely/0000-0002-9259-6643} } @article{MTMT:32181529, title = {Retrospective validation of coverage probability based simultaneous integrated nodal boost in locally advanced cervical cancer: a mono-institutional analysis}, url = {https://m2.mtmt.hu/api/publication/32181529}, author = {Kedves, András and Gulybán, Ákos and Glavák, Csaba and Toller, Gábor and Völgyi, Zoltán József and Faour, Amer and Bálint, András and Petrási, Bernadett and Rák, Tibor and Lakosi, Ferenc}, doi = {10.1080/0284186X.2021.1971293}, journal-iso = {ACTA ONCOL}, journal = {ACTA ONCOLOGICA}, volume = {61}, unique-id = {32181529}, issn = {0284-186X}, year = {2022}, eissn = {1651-226X}, pages = {202-205}, orcid-numbers = {Gulybán, Ákos/0000-0002-6805-8802; Glavák, Csaba/0000-0003-1448-810X} } @article{MTMT:32209047, title = {Retrospective validation of coverage probability based SIB-N in LACC a mono-institunional analysis}, url = {https://m2.mtmt.hu/api/publication/32209047}, author = {Kedves, András and Glavák, Csaba and Antal, Gergely and Toller, Gábor and Völgyi, Zoltán József and Faour, Amer and Petrási, Bernadett and Gulybán, Ákos and Lakosi, Ferenc}, journal-iso = {RADIOTHER ONCOL}, journal = {RADIOTHERAPY AND ONCOLOGY}, volume = {161}, unique-id = {32209047}, issn = {0167-8140}, year = {2021}, eissn = {1879-0887}, pages = {S647-S648}, orcid-numbers = {Glavák, Csaba/0000-0003-1448-810X; Antal, Gergely/0000-0002-9259-6643; Gulybán, Ákos/0000-0002-6805-8802} } @article{MTMT:31825183, title = {HDR brachytherapy boost using MR-only workflow for intermediate- and high-risk prostate cancer: 8-year results of a pilot study}, url = {https://m2.mtmt.hu/api/publication/31825183}, author = {Lakosi, Ferenc and Antal, Gergely and Páll, János and Farkas, Andrea and Jenei, Tibor and Nagy, Denes and Liptak, Jozsef and Sipocz, Istvan and Pytel, Ákos and Petőné Csima, Melinda and Gulybán, Ákos and Toller, Gábor}, doi = {10.1016/j.brachy.2020.12.003}, journal-iso = {BRACHYTHERAPY}, journal = {BRACHYTHERAPY}, volume = {20}, unique-id = {31825183}, issn = {1538-4721}, year = {2021}, eissn = {1873-1449}, pages = {576-583}, orcid-numbers = {Antal, Gergely/0000-0002-9259-6643; Petőné Csima, Melinda/0000-0001-8361-6385; Gulybán, Ákos/0000-0002-6805-8802} } @article{MTMT:31236689, title = {Lokálisan és lokoregionálisan előrehaladott, magas kockázatú endometriumtumorok műtét előtti szisztémás előkezelése}, url = {https://m2.mtmt.hu/api/publication/31236689}, author = {Kalincsák, Judit and Gőcze, Péter and Bohonyi, Noémi and Bárdos, Nikoletta and Koppán, Miklós and Kovács, Krisztina and Toller, Gábor and Petőné Csima, Melinda and Papp, Szilárd}, doi = {10.1556/650.2020.31614}, journal-iso = {ORV HETIL}, journal = {ORVOSI HETILAP}, volume = {161}, unique-id = {31236689}, issn = {0030-6002}, abstract = {Introduction: Endometrial cancer is the most common invasive gynecologic malignancy in developed countries. The best survival rates are expected after surgical removal, thus the aim of a complex treatment is to achieve resecability in locally and locoregionally advanced disease. Aim: The primary purpose of this study was to evaluate if the neoadjuvant systemic treatment leads to better overall survival compared to irradiation solely. Method: From January 2015 to December 2018, we enrolled 28 patients diagnosed with irresecable, locally and locoregionally advanced high-risk endometrial carcinoma. Patients were treated by neoadjuvant paclitaxel-carboplatin, then radical hysterectomy, bilateral oophorectomy and lymphadenectomy were performed. Results: After administration of 6 cycles of carboplatin-paclitaxel, the control MR test showed tumor shrinkage in all patients. Complete resection was achieved in the case of every patient. Tumor residuum in lymph nodes was verified in 4 cases by pathological evaluation. The 2-year survival and the 2-year progression-free survival rates were 65,1% and 66,1%, respectively. The median overall survival was 16,5 months. Conclusion: Neoadjuvant treatment can be an effective approach in providing the conditions for complete tumor resection, which may result in survival advantage. Despite multimodal treatment, prognosis is poor. Orv Hetil. 2020; 161(11): 425-433.}, keywords = {Neoadjuvant treatment; locally and locoregionally advanced endometrial carcinoma; lokálisan és lokoregionálisan előrehaladott endometriumcarcinoma; neoadjuváns kezelés; primary irresecable; primeren irreszekábilis}, year = {2020}, eissn = {1788-6120}, pages = {425-433} } @article{MTMT:30613859, title = {Initial experiences with coverage probability-based nodal SIB RT in cervical cancer}, url = {https://m2.mtmt.hu/api/publication/30613859}, author = {Glavák, Csaba and Toller, Gábor and Völgyi, Zoltán József and Faour, Amer and Balint, A and Miovecz, Ádám and Kisiván, Katalin and Repa, Imre and Hadjiev, Janaki and Lakosi, Ferenc}, doi = {10.1016/S0167-8140(18)31124-1}, journal-iso = {RADIOTHER ONCOL}, journal = {RADIOTHERAPY AND ONCOLOGY}, volume = {127}, unique-id = {30613859}, issn = {0167-8140}, year = {2018}, eissn = {1879-0887}, orcid-numbers = {Glavák, Csaba/0000-0003-1448-810X; Hadjiev, Janaki/0000-0003-4419-353X} } @CONFERENCE{MTMT:30391951, title = {OnkoNetwork – Iránytű az útvesztőben}, url = {https://m2.mtmt.hu/api/publication/30391951}, author = {Vinczen, Eszter and Nemes-Vargha, Barbara and Repa, Krisztina and Toller, Gábor and Hadjiev, Janaki and Repa, Imre}, booktitle = {XXI. MRAE kongresszus}, unique-id = {30391951}, year = {2018}, pages = {online}, orcid-numbers = {Hadjiev, Janaki/0000-0003-4419-353X} }